「in vitroinvivoin vitroinvivo」の検索結果
162件：101～105件目を表示
-
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann...
https://www.senju.co.jp/english/news/ -
ysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Jap...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical
The success of our premier line of ophthalmological drugs has launched our entry into other promising fields of medicine Senju Pharmaceutical greatly values the clinical experience of medical professi...
https://www.senju.co.jp/english/about/business/mp.html -
お知らせ | 千寿製薬株式会社
2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel sub...
http://www.senju.co.jp/chinese/news/ -
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
https://www.senju.co.jp/english/about/message.html